These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16052694)

  • 21. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The expression and localization of p27(KIP1)-GFP fusion gene in hepatocellular carcinoma cell lines].
    Zheng JY; Li J; Li KZ; Wang WL; Wang WZ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 May; 19(3):218-20. PubMed ID: 15155074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma.
    Qin J; Wang Z; Wang Y; Ma L; Ni Q; Ke J
    Hepatogastroenterology; 2010; 57(99-100):547-53. PubMed ID: 20698225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
    Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
    Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleostemin/GNL3 promotes nucleolar polyubiquitylation of p27
    Hu B; Hua L; Ni W; Wu M; Yan D; Chen Y; Lu C; Chen B; Wan C
    Cancer Lett; 2017 Mar; 388():220-229. PubMed ID: 27998760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
    Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
    Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
    Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity.
    Ranchal I; González R; Bello RI; Ferrín G; Hidalgo AB; Linares CI; Aguilar-Melero P; González-Rubio S; Barrera P; Marchal T; Nakayama KI; de la Mata M; Muntané J
    Int J Cancer; 2009 Nov; 125(10):2270-80. PubMed ID: 19672859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
    Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
    PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of the p27(kip1) gene in hepatocellular carcinoma.
    Chen TC; Ng KF; Lien JM; Jeng LB; Chen MF; Hsieh LL
    Cancer Lett; 2000 May; 153(1-2):169-73. PubMed ID: 10779646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
    Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
    J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
    Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis.
    Matsuda Y; Ichida T
    Med Mol Morphol; 2006 Dec; 39(4):169-75. PubMed ID: 17187177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma].
    Zhang CJ; Li HM; Yau LM; Suen KW; Zhou GY; Yu F; Liew CT
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):433-6. PubMed ID: 15498213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
    Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis.
    Yachida S; Imaida K; Yokohira M; Hashimoto N; Suzuki S; Okano K; Wakabayashi H; Maeta H; Suzuki Y
    Ann Surg Oncol; 2010 Dec; 17(12):3386-93. PubMed ID: 20589433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.